142 related articles for article (PubMed ID: 8664123)
1. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
Lösch A; Kohlberger P; Gitsch G; Kaider A; Breitenecker G; Kainz C
Br J Cancer; 1996 Jun; 73(12):1525-8. PubMed ID: 8664123
[TBL] [Abstract][Full Text] [Related]
2. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
[TBL] [Abstract][Full Text] [Related]
3. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma.
Nazeer T; Malfetano JH; Rosano TG; Ross JS
Am J Clin Pathol; 1992 Jun; 97(6):764-9. PubMed ID: 1595596
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies concerning cathepsin D in endometrial carcinomas.
Inoue Y; Abe K; Obata K; Doh K; Ohmura G; Hoshiai H; Noda K
J Obstet Gynaecol Res; 1999 Oct; 25(5):345-52. PubMed ID: 10533331
[TBL] [Abstract][Full Text] [Related]
5. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
6. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome.
Gassel AM; Backe J; Krebs S; Schön S; Caffier H; Müller-Hermelink HK
J Clin Pathol; 1998 Jan; 51(1):25-9. PubMed ID: 9577367
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
10. [The prognostic value of cathepsin D in endometrial carcinoma].
Köhler U; Langanke D; Sorger D; Martin R; Bilek K
Zentralbl Gynakol; 1995; 117(3):148-52. PubMed ID: 7740849
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
12. Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer.
Falcón O; Chirino R; León L; López-Bonilla A; Torres S; Fernández L; García-Hernández JA; Valerón PF; Díaz-Chico JC
Br J Cancer; 1999 Feb; 79(3-4):570-6. PubMed ID: 10027332
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Devetzi M; Scorilas A; Tsiambas E; Sameni M; Fotiou S; Sloane BF; Talieri M
Gynecol Oncol; 2009 Mar; 112(3):531-6. PubMed ID: 19110306
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.
Pujol P; Maudelonde T; Daures JP; Rouanet P; Brouillet JP; Pujol H; Rochefort H
Cancer; 1993 Mar; 71(6):2006-12. PubMed ID: 8443752
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618
[TBL] [Abstract][Full Text] [Related]
18. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.
Moul JW; Maygarden SJ; Ware JL; Mohler JL; Maher PD; Schenkman NS; Ho CK
J Urol; 1996 Mar; 155(3):982-5. PubMed ID: 8583622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
